154 related articles for article (PubMed ID: 15621277)
1. New liposome-encapsulated-polyoxometalates: synthesis and antitumoral activity.
Wang X; Li F; Liu S; Pope MT
J Inorg Biochem; 2005 Feb; 99(2):452-7. PubMed ID: 15621277
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of polyoxometalates loaded starch nanocomplex and its antitumoral activity.
Zhai F; Li D; Zhang C; Wang X; Li R
Eur J Med Chem; 2008 Sep; 43(9):1911-7. PubMed ID: 18440097
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and antitumoral activity of polyoxometalate loaded starch nanocomplexes.
Wang X; Xu L; Li Y; Li F
J Nanosci Nanotechnol; 2005 Jun; 5(6):905-8. PubMed ID: 16060151
[TBL] [Abstract][Full Text] [Related]
4. pH-responsive controlled release of antitumour-active polyoxometalate from mesoporous silica materials.
Sun G; Chang Y; Li S; Li Q; Xu R; Gu J; Wang E
Dalton Trans; 2009 Jun; (23):4481-7. PubMed ID: 19488446
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterisation and cytotoxicity of polyoxometalate/carboxymethyl chitosan nanocomposites.
Geisberger G; Paulus S; Carraro M; Bonchio M; Patzke GR
Chemistry; 2011 Apr; 17(16):4619-25. PubMed ID: 21322072
[TBL] [Abstract][Full Text] [Related]
6. The synthesis of silica nanospheres doped with polyoxometalates.
Green M; Harries J; Wakefield G; Taylor R
J Am Chem Soc; 2005 Sep; 127(37):12812-3. PubMed ID: 16159270
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis, spectroscopic characterization and antitumoral activities of cyclopentadienylvanadium derivatives of polyoxotungstates].
Liu JT; Lu YF; Fan SD
Guang Pu Xue Yu Guang Pu Fen Xi; 2012 Sep; 32(9):2512-4. PubMed ID: 23240428
[TBL] [Abstract][Full Text] [Related]
8. Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivo.
Dong Z; Tan R; Cao J; Yang Y; Kong C; Du J; Zhu S; Zhang Y; Lu J; Huang B; Liu S
Eur J Med Chem; 2011 Jun; 46(6):2477-84. PubMed ID: 21481498
[TBL] [Abstract][Full Text] [Related]
9. Mesomorphic structures of protonated surfactant-encapsulated polyoxometalate complexes.
Yin S; Li W; Wang J; Wu L
J Phys Chem B; 2008 Apr; 112(13):3983-8. PubMed ID: 18327934
[TBL] [Abstract][Full Text] [Related]
10. In vitro antitumor activity of parent and nano-encapsulated mono cobalt-substituted Keggin polyoxotungstate and its ctDNA binding properties.
Dianat S; Bordbar AK; Tangestaninejad S; Yadollahi B; Zarkesh-Esfahani SH; Habibi P
Chem Biol Interact; 2014 May; 215():25-32. PubMed ID: 24613453
[TBL] [Abstract][Full Text] [Related]
11. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives.
Stanchev S; Momekov G; Jensen F; Manolov I
Eur J Med Chem; 2008 Apr; 43(4):694-706. PubMed ID: 17614164
[TBL] [Abstract][Full Text] [Related]
13. A new class of functionalized polyoxometalates: synthesis, structure and preliminary antitumor activity studies of three arylimido substituted hexamolybdates bearing a strong electron-withdrawing nitro group, (Bu4N)2[Mo6O18([triple bond]NAr)] (Ar = 3-NO2-C6H4, 2-CH3-4-NO2-C6H3, 2-CH3-5-NO2-C6H3).
Xue S; Chai A; Cai Z; Wei Y; Xiang C; Bian W; Shen J
Dalton Trans; 2008 Sep; (35):4770-5. PubMed ID: 18728886
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro cytotoxicity of novel lipophilic (diamine)platinum(II) complexes of salicylate derivatives.
Ye QS; Lou LG; Liu WP; Yu Y; Chen XZ; Hou SQ; Gao WQ; Liu Y
Bioorg Med Chem Lett; 2007 Apr; 17(8):2146-9. PubMed ID: 17306532
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumoral activity of gelatin/polyoxometalate hybrid nanoparticles.
Guo R; Cheng Y; Ding D; Li X; Zhang L; Jiang X; Liu B
Macromol Biosci; 2011 Jun; 11(6):839-47. PubMed ID: 21416607
[TBL] [Abstract][Full Text] [Related]
16. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
[TBL] [Abstract][Full Text] [Related]
17. Palladium(II) complexes with R2edda-derived ligands. Part II. Synthesis, characterization and in vitro antitumoral studies of R2eddip esters and palladium(II) complexes.
Zmejkovski BB; Kaluderović GN; Gómez-Ruiz S; Zizak Z; Steinborn D; Schmidt H; Paschke R; Juranić ZD; Sabo TJ
Eur J Med Chem; 2009 Sep; 44(9):3452-8. PubMed ID: 19272676
[TBL] [Abstract][Full Text] [Related]
18. Preparation and application of multiple-component-doped keggin polyoxometalate microtubes--towards a component-tunable hollow structure.
Shen Y; Peng J; Pang H; Zhang P; Chen D; Chen C; Zhang H; Meng C; Su Z
Chemistry; 2011 Mar; 17(13):3657-62. PubMed ID: 21344513
[TBL] [Abstract][Full Text] [Related]
19. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes.
Pérez-Quintanilla D; Gómez-Ruiz S; Zizak Z; Sierra I; Prashar S; del Hierro I; Fajardo M; Juranić ZD; Kaluderović GN
Chemistry; 2009; 15(22):5588-97. PubMed ID: 19370742
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI), and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines.
Thomadaki H; Karaliota A; Litos C; Scorilas A
J Med Chem; 2007 Mar; 50(6):1316-21. PubMed ID: 17328533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
